Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacy.
Sabatos-Peyton CA, Nevin J, Brock A, Venable JD, Tan DJ, Kassam N, Xu F, Taraszka J, Wesemann L, Pertel T, Acharya N, Klapholz M, Etminan Y, Jiang X, Huang YH, Blumberg RS, Kuchroo VK, Anderson AC. Sabatos-Peyton CA, et al. Among authors: tan dj. Oncoimmunology. 2017 Nov 9;7(2):e1385690. doi: 10.1080/2162402X.2017.1385690. eCollection 2018. Oncoimmunology. 2017. PMID: 29308307 Free PMC article.
TIGIT predominantly regulates the immune response via regulatory T cells.
Kurtulus S, Sakuishi K, Ngiow SF, Joller N, Tan DJ, Teng MW, Smyth MJ, Kuchroo VK, Anderson AC. Kurtulus S, et al. Among authors: tan dj. J Clin Invest. 2024 Jul 1;134(13):e183278. doi: 10.1172/JCI183278. J Clin Invest. 2024. PMID: 38949028 Free PMC article. No abstract available.
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.
Glaviano A, Lau HS, Carter LM, Lee EHC, Lam HY, Okina E, Tan DJJ, Tan W, Ang HL, Carbone D, Yee MY, Shanmugam MK, Huang XZ, Sethi G, Tan TZ, Lim LHK, Huang RY, Ungefroren H, Giovannetti E, Tang DG, Bruno TC, Luo P, Andersen MH, Qian BZ, Ishihara J, Radisky DC, Elias S, Yadav S, Kim M, Robert C, Diana P, Schalper KA, Shi T, Merghoub T, Krebs S, Kusumbe AP, Davids MS, Brown JR, Kumar AP. Glaviano A, et al. Among authors: tan djj. J Hematol Oncol. 2025 Jan 13;18(1):6. doi: 10.1186/s13045-024-01634-6. J Hematol Oncol. 2025. PMID: 39806516 Free PMC article. Review.
Artificial Intelligence and Machine Learning Predicting Transarterial Chemoembolization Outcomes: A Systematic Review.
Cho EEL, Law M, Yu Z, Yong JN, Tan CS, Tan EY, Takahashi H, Danpanichkul P, Nah B, Soon GST, Ng CH, Tan DJH, Seko Y, Nakamura T, Morishita A, Chirapongsathorn S, Kumar R, Kow AWC, Huang DQ, Lim MC, Law JH. Cho EEL, et al. Among authors: tan djh. Dig Dis Sci. 2024 Dec 21. doi: 10.1007/s10620-024-08747-5. Online ahead of print. Dig Dis Sci. 2024. PMID: 39708260
Associations between life-course FEV1/FVC trajectories and respiratory symptoms up to middle age: analysis of data from two prospective cohort studies.
Perret JL, Bui DS, Pistenmaa C, Vicendese D, Khan SS, Han MK, San José Estépar R, Lowe AJ, Lodge CJ, Labaki WW, Pham JV, Idrose NS, Senaratna CV, Tan DJ, Hamilton GS, Thompson BR, Munsif M, Arynchyn A, Jacobs DR Jr, Abramson MJ, Walters EH, Washko GR, Kalhan R, Dharmage SC; AUSCULTATE investigator group. Perret JL, et al. Among authors: tan dj. Lancet Respir Med. 2024 Nov 27:S2213-2600(24)00265-0. doi: 10.1016/S2213-2600(24)00265-0. Online ahead of print. Lancet Respir Med. 2024. PMID: 39615504
211 results